
GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
| Revenue (TTM) | $20.98B |
| Gross Profit (TTM) | $8.21B |
| EBITDA | $3.52B |
| Operating Margin | 11.10% |
| Return on Equity | 19.50% |
| Return on Assets | 5.17% |
| Revenue/Share (TTM) | $46.03 |
| Book Value | $23.45 |
| Price-to-Book | 2.61 |
| Price-to-Sales (TTM) | 1.39 |
| EV/Revenue | 1.722 |
| EV/EBITDA | 10.03 |
| Quarterly Earnings Growth (YoY) | -30.90% |
| Quarterly Revenue Growth (YoY) | 7.40% |
| Shares Outstanding | $454.89M |
| Float | $453.43M |
| % Insiders | 0.35% |
| % Institutions | 95.00% |
Volatility is currently expanding

GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.

GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript

GE HealthCare Technologies NASDAQ: GEHC reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issues.

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.06 per share a year ago.

GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Donald Trump.

Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to di.

GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the introduction of MIM Anyware™, a remote access platform that provides secure, healthcare system-controlled access to imaging data through a web browser without requiring local software installation. By enabling authorized users to access MIM software applications from virtually any location, MIM Anyware is designed to support collaboration across departments and clinical decision-making. Today, healthcare systems are mana.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on GEHC and any ticker you trade — then tracks every position and per-strategy win rate.